FDA Drug Recalls

Recalls / Class II

Class IID-0334-2022

Product

CAREONE Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine, 24HR, packaged as a)30 count bottle, NDC 41520-229-39, UPC 3 41520 31984 6; b)45 count bottle, NDC 41520-229-95 UPC 3 41520 31983 9; Made in the Czech Republic, Distributed by: Foodhold U.S.A. LLC Landover, MD 20785. Made in Czech Republic

Brand name
Careone Allergy Relief
Generic name
Fexofenadine Hcl
Active ingredient
Fexofenadine Hydrochloride
Route
Oral
NDC
41520-229
FDA application
ANDA076447
Affected lot / code info
Lot a) 0FR0459, Exp 2/28/2022; 0LR0362, Exp 6/30/2022; 1BR0462, Exp 10/31/2022 b) 0LR0363, Exp 6/30/2022

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Recalling firm

Firm
Perrigo Company PLC
Manufacturer
American Sales Company
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
28776 containers
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-07-27
FDA classified
2022-01-05
Posted by FDA
2022-01-12
Terminated
2022-11-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0334-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Careone Allergy Relief · FDA Drug Recalls